Polymerized type I collagen improves the mean oxygen saturation and efficiently shortens symptom duration and hospital stay in adult hospitalized patients with moderate to severe COVID-19: Randomized controlled clinical trial
- Journal of Anesthesia & Critical Care: Open Access
-
Jorge R. Melchor-Amador, MD, Eduardo Mota-González, MD, Sonia M. Amador-Ayestas, MD, Mariely Castelán-López, MD, Adriana M. Vidal-Mendez, MD, Jessica A. Ojeda Guevara, MD, Katy Palma-Vázquez, MD, A. Arizahi Ríos-Lina
Abstract
To evaluate the safety and clinical efficacy of intramuscular administration of polymerized type I collagen (PTIC) in adult hospitalized patients with moderate to severe COVID-19 on mean oxygen saturation and symptom duration.
Keywords
COVID-19